|
|
DSpace at RU >
Browsing by Author Seynaeve, C.
Showing results 1 to 30 of 30
| Full Text | Issue Date | Title | Author(s) | | 2012 | Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline | de Vos, F.Y.; Laarhoven, H.W.M. van; Laven, J.S.E.; Themmen, A.P.N.; Beex, L.V.A.M., et al |
| 2012 | Relevant impact of central pathology review on nodal classification in individual breast cancer patients | Vestjens, J.H.; Pepels, M.J.; Boer, M. de; Borm, G.F.; Deurzen, C.H. van, et al |
| 2012 | Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. | Kirchhoff, T.; Gaudet, M.M.; Antoniou, A.C.; McGuffog, L.; Humphreys, M.K., et al |
| 2012 | Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial | Saadatmand, S.; Rutgers, E.J.; Tollenaar, R.A.E.M.; Zonderland, H.M.; Ausems, M.G., et al |
| 2012 | The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer. | Heijer, M. den; Vos, J.; Seynaeve, C.; Vanheusden, K.; Duivenvoorden, H.J., et al |
| 2012 | Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study | Schilder, C.M.; Seynaeve, C.; Linn, S.C.; Boogerd, W.; Beex, L.V.A.M., et al |
| 2012 | Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. | Jakubowska, A.; Rozkrut, D.; Antoniou, A.; Hamann, U.; Scott, R.J., et al |
| 2012 | Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. | Heijer, M. den; Seynaeve, C.; Timman, R.; Duivenvoorden, H.J.; Vanheusden, K., et al |
| 2011 | Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment | Graan, A.J. de; Teunissen, S.F.; Vos, F.Y. de; Loos, W.J.; Schaik, R.H. van, et al |
| 2011 | The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients | Schaik, R.H. van; Kok, M. de; Sweep, F.C.; Vliet, M. van; Fessem, M. van, et al |
| 2011 | Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 | Mulligan, A.M.; Couch, F.J.; Barrowdale, D.; Domchek, S.M.; Eccles, D., et al |
| 2010 | BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. | Rijnsburger, A.J.; Obdeijn, I.M.; Kaas, R.; Tilanus-Linthorst, M.M.; Boetes, C., et al |
| 2010 | Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. | Schilder, C.M.; Seynaeve, C.; Beex, L.V.A.M.; Boogerd, W.; Linn, S.C., et al |
| 2010 | The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. | Schilder, C.M.; Seynaeve, C.; Linn, S.C.; Boogerd, W.; Gundy, C.M., et al |
| 2010 | Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial. | Nes, J.G. van; Seynaeve, C.; Maartense, E.; Roumen, R.M.; Jong, R.S. de, et al |
| 2010 | Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. | Schilder, C.M.; Seynaeve, C.; Linn, S.C.; Boogerd, W.; Beex, L.V.A.M., et al |
| 2009 | Micrometastases or isolated tumor cells and the outcome of breast cancer. | Boer, M. de; Deurzen, C.H. van; Dijck, J.A.A.M. van; Borm, G.F.; Diest, P.J. van, et al |
| 2009 | No evidence that GATA3 rs570613 SNP modifies breast cancer risk. | Johnatty, S.E.; Couch, F.J.; Fredericksen, Z.; Tarrell, R.; Spurdle, A.B., et al |
| 2007 | The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al |
| 2007 | Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy? | Bresser, P.J.; Gool, A.R. van; Seynaeve, C.; Duivenvoorden, H.J.; Niermeijer, M.F., et al |
| 2007 | Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer | Kriege, M.; Brekelmans, C.T.; Peterse, H.; Obdeijn, I.M.; Boetes, C., et al |
| 2007 | Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al |
| 2007 | The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. | Bresser, P.J.; Seynaeve, C.; Gool, A.R. van; Niermeijer, M.F.; Duivenvoorden, H.J., et al |
| 2007 | A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al |
| 2007 | Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al |
| 2007 | Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing. | Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al |
| 2006 | Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. | Kriege, M.; Brekelmans, C.T.; Obdeijn, I.M.; Boetes, C.; Zonderland, H.M., et al |
| 2005 | Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. | Nieboer, P.; Buijs, C.; Rodenhuis, S.; Seynaeve, C.; Beex, L.V.A.M., et al |
| 2005 | Richtlijn 'Diagnostiek bij wekedelentumoren en behandeling van wekedelensarcomen (herziening)' | Geel, A.N. van; Wyrdeman, H.K.; Seynaeve, C.; Hogendoorn, P.C.; Bongaerts, A.H., et al |
| 2004 | Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. | Seynaeve, C.; Verhoog, L.C.; Bosch, L.M. van de; Geel, A.N. van; Menke-Pluymers, M., et al |
Showing results 1 to 30 of 30
|